Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

cce3c732110ba85e5c720b2968bb007b96117ae5c235af302c2c15bddad2b009

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD, Per Share]

EPS - Diluted [USD, Per Share]

e464816929e99159ae47b2b18805a58d866bcff895037f748848b5357017fb5e

9d7be43b076bfbc8948cbe482aff0a2a80447da23daa96072ad16af1822ad59e

Unit Volume Growth for MedSurg and Neurotechnology (percentage)

Unit Volume Growth for Orthopaedics and Spine (percentage)

Unit Volume Growth (Consolidated) (percentage)

26a3120e8ad5f92fcd3c39b543e064054aa4d39232d9b197dab2111372572d4d

United States

International

- Europe, Middle East, Africa

- Asia Pacific

- Other countries

Total Revenue

218eea8b4bc613764123186a37310692775aa8955abc9281af625c2f41afb5d5

914136f68b6e97011d5c1948c58b28a73dcce6e8668c4c1dbc93fdea70b3aeef

Cash and cash equivalents (USD, millions)

Short-term investments (USD, millions)

Marketable securities (USD, millions)

Accounts receivable, net (USD, millions)

Total inventories (USD, millions)

Prepaid expenses and other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Noncurrent deferred income tax assets (USD, millions)

Other noncurrent assets (USD, millions)

Total assets (USD, millions)

Total current liabilities (USD, millions)

Long-term debt, excluding current maturities (USD, millions)

Other noncurrent liabilities (USD, millions)

Total shareholders' equity (USD, millions)

Total liabilities & shareholders' equity (USD, millions)

b96a71ffd2cdeb230090896aa50af9aad14f855de3846f7a884ce952c5831c78

Net earnings (USD, millions)

Depreciation (USD, millions)

Amortization of intangible assets (USD, millions)

Net cash provided by operating activities (USD, millions)

Acquisitions, net of cash acquired (USD, millions)

Proceeds from sales of marketable securities (USD, millions)

Purchases of property, plant and equipment (USD, millions)

Other investing, net (USD, millions)

Net cash used in investing activities (USD, millions)

Payments of dividends (USD, millions)

Other financing, net (USD, millions)

Net cash provided by (used in) financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents (USD, millions)

Change in cash and cash equivalents (USD, millions)

ecaedc857d2d99565e83dec8c8cd7d3042bc57b2dddbbbe88c9ef858a7a24db1

Net Sales (USD, millions)

Cost of Sales (USD, millions)

Gross Profit (USD, millions)

Research, Development and Engineering Expenses (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Amortization of Intangible Assets (USD, millions)

Goodwill and Other Impairments (USD, millions)

Total Operating Expenses (USD, millions)

Operating Income (USD, millions)

Other Income (Expense), Net (USD, millions)

Earnings Before Income Taxes (USD, millions)

Income Taxes (USD, millions)

Net Earnings (USD, millions)

Net Earnings per Share of Common Stock - Basic (USD)

Net Earnings per Share of Common Stock - Diluted (USD)

be7304c63d29209c223268bec8a4d9c33699ce28fbf2ff736d5dcf09305d4f54

Stryker Corp (SYK)

Financials